ISMP Canada and ISMP strongly encourage manufacturers to make Lugol's solution available for purchase in smaller volumes that would contain less than a lethal dose of iodine. Manufacturers should also ...

Base of tongue squamous cell carcinoma susceptibility: Novel candidate genetic polymorphisms identified in genome-wide association study. This is an ASCO Meeting Abstract from the 2012 ASCO Annual ...

IODIDE therapy as practiced today pays little attention to the precise needs of the individual patient. The dosage of saturated solution of potassium iodide varies arbitrarily from a few drops to 1 ml ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. Dysplasia can range from being slightly abnormal to very abnormal. Cancer is more likely to ...

Researchers and doctors around the world are leaving no stone unturned to find ways to stop the ongoing COVID-19 pandemic. Marking a breakthrough in the search for a cure for the deadly disease, a ...

RDAs are set to show the amount required to meet the needs of 97 to 98 percent of healthy people. When there’s not strong enough evidence to show what the RDA is for a certain nutrient, adequate ...

Dispense Lugol's solution in a quantity appropriate for the intended and safe use of the medication—never in quantities that could be lethal if consumed as a single dose. For oral treatment of an ...

This trial is no longer recruiting patients. We hope to add results when they are available. This trial is for people having surgery to remove abnormal cells from the lining of their mouth or part of ...